Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity

NCT07469800 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity
Hypertensive

Interventions

DRUG: IBI362
DRUG: Placebo

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.